View in EDS

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).

Saved in:
Bibliographic Details
Title: A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).
Authors: Slingluff CL Jr; Department of Surgery, Human Immune Therapy Center, University of Virginia, Charlottesville, Virginia, USA. cls8h@virginia.edu, Lee S, Zhao F, Chianese-Bullock KA, Olson WC, Butterfield LH, Whiteside TL, Leming PD, Kirkwood JM
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Aug 01; Vol. 19 (15), pp. 4228-38. Date of Electronic Publication: 2013 May 07.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 23653149
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Slingluff+CL+Jr%22">Slingluff CL Jr</searchLink>; Department of Surgery, Human Immune Therapy Center, University of Virginia, Charlottesville, Virginia, USA. cls8h@virginia.edu<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink><br /><searchLink fieldCode="AU" term="%22Zhao+F%22">Zhao F</searchLink><br /><searchLink fieldCode="AU" term="%22Chianese-Bullock+KA%22">Chianese-Bullock KA</searchLink><br /><searchLink fieldCode="AU" term="%22Olson+WC%22">Olson WC</searchLink><br /><searchLink fieldCode="AU" term="%22Butterfield+LH%22">Butterfield LH</searchLink><br /><searchLink fieldCode="AU" term="%22Whiteside+TL%22">Whiteside TL</searchLink><br /><searchLink fieldCode="AU" term="%22Leming+PD%22">Leming PD</searchLink><br /><searchLink fieldCode="AU" term="%22Kirkwood+JM%22">Kirkwood JM</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2013 Aug 01; Vol. 19 (15), pp. 4228-38. <i>Date of Electronic Publication: </i>2013 May 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23653149
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-13-0002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4228
    Titles:
      – TitleFull: A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Slingluff CL Jr
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Zhao F
      – PersonEntity:
          Name:
            NameFull: Chianese-Bullock KA
      – PersonEntity:
          Name:
            NameFull: Olson WC
      – PersonEntity:
          Name:
            NameFull: Butterfield LH
      – PersonEntity:
          Name:
            NameFull: Whiteside TL
      – PersonEntity:
          Name:
            NameFull: Leming PD
      – PersonEntity:
          Name:
            NameFull: Kirkwood JM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2013 Aug 01
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 15
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1